Scholar Rock Holding Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated May 27, 2022, discloses the results of the annual meeting of stockholders held on May 26, 2022. Scholar Rock Holding Corp. is a biopharmaceutical company incorporated in Delaware and listed on the Nasdaq Global Market under the symbol SRRK.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes rather than financial performance.
Material Changes
No material financial changes are reported in this document. The primary event is the completion of the annual stockholder vote.
Outlook, Risks, and Voting Results
The stockholders approved two key proposals:
- Proposal 1 (Election of Directors): Stockholders elected two Class I directors for a three-year term expiring in 2025.
- Nagesh Mahanthappa, Ph.D.: 24,557,780 votes for; 4,060,669 votes withheld.
- Joshua Reed: 24,380,745 votes for; 4,237,704 votes withheld.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Votes For: 30,692,469
- Votes Against: 38
- Abstentions: 108,146
Key Facts for Investor Verification
- Verify the full composition of the Board of Directors following the election of the Class I directors.
- Review the definitive proxy statement filed on April 13, 2022, for detailed biographies of the elected directors and the rationale for the auditor appointment.
- Confirm the company's financial status in the most recent 10-Q or 10-K filing, as this 8-K contains no financial data.